title: Benefits of reoperation of T2 and more advanced incidental gallbladder carcinoma: analysis of the German registry.
abstract: OBJECTIVE
  The aim of this study was to determine which T stages of incidental gallbladder carcinoma (IGBC) actually benefit from an early reresection (ERR).
  
  
  BACKGROUND
  The IGBC is a carcinoma first detected by the pathologist. The indication for the cholecystectomy was a benign disease. The indication for an ERR is debated in the literature, and different recommendations are often drawn based on data collected from only small groups.
  
  
  METHODS
  A register was founded in 1997 to prospectively record all IGBCs in Germany. All the patients who had a reresection in this study were treated according to the German Guidelines of Surgery and Oncology. This study analyzes 439 cases of IGBC.
  
  
  RESULTS
  There was a significant benefit for the 85 of 200 T2 patients who did have an ERR. There was no benefit though for the 32 of 85 T3 patients who did have an ERR. There is a significantly better survival rate for T2 patients with negative lymph nodes, and there is a trend for better survival for T3 patients with negative lymph nodes.
  
  
  CONCLUSIONS
  An ERR should be highly recommended for patients with IGBC in the T2 stage, because it improves their survival positive. Without an ERR, it is almost impossible to definitively determine the nodal status or to obtain exact staging for estimating the prognosis.
authors.affiliation: Department of Surgery, Ketteler-Krankenhaus, Offenbach, Germany. ThGoetze@aol.com
authors.forename: Thorsten Oliver
authors.initials: TO
authors.lastname: Goetze
authors.forename: Vittorio
authors.initials: V
authors.lastname: Paolucci
mesh_terms: D000368:Aged; D002763:Cholecystectomy; D005260:Female; D005706:Gallbladder Neoplasms / Q000473:pathology* / Q000601:surgery*; D005858:Germany / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008207:Lymphatic Metastasis; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D011446:Prospective Studies; D012042:Registries; D012086:Reoperation; D011795:Surveys and Questionnaires; D015996:Survival Rate; D016896:Treatment Outcome